蒂米丁激酶1 (TK1) 作为癌症中的蛋白质生物标志物
Vijaya Paul Samuel1, Muhammad Afzal2, M Arockia Babu3
1Department of Anatomy, RAK Medical & Health Sciences University, Ras Al Khaimah College of Medical Sciences, Ras Al Khaimah, United Arab Emirates.
Clinica chimica acta; international journal of clinical chemistry
|November 3, 2025
概括
血清蒂米丁激酶1 (TK1) 是一种有价值的癌症生物标志物. 现代的酶链免疫测试提供了改进的检测,帮助诊断,预后和早期癌症预警在各种瘤类型.
科学领域:
- 癌症实验室医学 癌症实验室医学
- 生物化学分析 生物化学分析
- 癌症诊断 癌症诊断 癌症诊断
背景情况:
- 血清蒂米丁激酶1 (TK1) 是细胞增殖的一个关键生物标志物.
- 传统的放射性同位素测试正在被更容易获得的酶相关免疫测试 (ELISA) 取代.
- TK1已经在瘤学中建立了诊断和预后作用.
研究的目的:
- 审查TK1检测系统的演变和分析能力.
- 评估血清TK1在各种恶性瘤中的临床效用.
- 评估TK1在癌症诊断,预后和查中的作用.
主要方法:
- 108项高质量研究的系统审查.
- 从15,000多名患者的数据分析临床证据.
- 包括超过47,000个人的人口查数据.
- 检查现代双单克隆ELISA系统及其分析性能.
主要成果:
- 现代ELISA提供了更好的检测极限 (0.12 ng/mL) 和精度 (5-15%).
- 血清TK1与各种癌症的瘤负担,阶段和治疗反应相关.
- 将TK1与其他生物标志物的结合提高了诊断准确度 (AUC 0.79-0.96).
- 在基于人群的癌症查中,TK1显示出高精度 (96%),并预测生存率.
结论:
- 血清TK1是一种用于癌症诊断,预后和早期检测的多功能生物标志物.
- 标准化,参考间隔和质量保证是广泛实施的关键.
- 需要进一步的研究来优化TK1测试的统一性和自动化,以便精确的癌症诊断.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


